Resonance Health Limited (ASX:RHT)

Australia · Delayed Price · Currency is AUD

0.0600

+0.0040 (7.14%)

Jul 29, 2026, 3:50 PM AEST

Resonance Health Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	13.84	11.07	8.59	4.4	3.85	3.78
Revenue Growth	24.97%	28.91%	95.02%	14.31%	1.96%	3.02%
Gross Profit	13.84	11.07	8.59	4.4	3.85	3.78
Operating Income	0.94	-1.58	-0.53	-1.36	-1.52	0.4
Net Income	0.77	-1.73	0.17	-0.78	-1.14	0.59
Earnings Per Share	0.00	-0.00	0.00	-0.00	-0.00	0.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Resonance Clinical	-	4.16	3.93
Intersegment Elimination	-1.94	-1.01	-0.23
Trialswest	2.95	2.66	0.35
Research & Development	-	5.27	4.54
Total	13.84	11.07	8.59

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	2.69	2.98	6.85	6.36	6.78	8.86
Total Debt	4.05	3.8	3.7	0.27	0.27	0.06
Net Cash (Debt)	-1.36	-0.83	3.16	6.09	6.51	8.8
Net Cash Growth	-	-	-48.13%	-6.54%	-25.94%	28.27%
Net Cash Per Share	-0.00	-0.00	0.01	0.01	0.01	0.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	0.42	1.25	1.39	-0.16	-1.46	1.17
Capital Expenditures	-0.37	-0.44	-0.23	-0.29	-0.12	-0.04
Free Cash Flow	0.05	0.81	1.16	-0.45	-1.57	1.13
Free Cash Flow Growth	-94.18%	-30.45%	-	-	-	-13.77%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	6.77%	-14.30%	-6.16%	-30.89%	-39.57%	10.58%
Pretax Margin	1.56%	-19.86%	-7.30%	-28.70%	-40.27%	9.09%
Profit Margin	5.56%	-15.65%	1.97%	-17.72%	-29.63%	15.50%
FCF Margin	0.34%	7.27%	13.48%	-10.11%	-40.86%	29.86%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	36.88	-	155.74	-	-	122.01
P/FCF Ratio	610.32	22.26	22.77	-	-	63.34
PS Ratio	2.07	1.62	3.07	4.40	6.70	18.92